Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Promises Million-SNP Genotyping Product for Summer 2006

NEW YORK, March 15 (GenomeWeb News) - Illumina plans to release a genotyping product by June 2006 that will allow researchers to analyze one million SNPs, the San Diego-based company said today.

 

The product, based on a pair of Sentrix BeadChips, will use the company's Infinium assay, which does not rely on PCR. Before it launches the one-million-SNP product, Illumina plans to release BeadChips containing 250,000 and 500,000 SNP markers.

 

Illumina will work with a customer consortium to determine the SNP content of the BeadChips.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.